Takeda Pharmaceutical Company Limited
PURIFICATION OF FACTOR VIII SUBSPECIES
Last updated:
Abstract:
The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.
Status:
Application
Type:
Utility
Filling date:
7 Mar 2022
Issue date:
1 Sep 2022